Fair Value Calculator Fair Value Calculator
EN DE

AMAGI (AMAGI) Fair Value & Analysis

Technology · Market cap ₹117B

A AMAGI AMAGI · NSE
Price₹539.50
Fair Value₹56.32
Upside-89.6%
Quality61/100
Watch AMAGI for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹42.24 – ₹70.40

Fair value as of: Jul 3, 2026

From 15 valuation models · updated today

Share price +26.8% over the past month.

Price vs Fair Value (5 months)

₹560.55 ₹316.70 Fair Value ₹56.32 Jan 2026 Jul 2026

5‑month range ₹316.70 – ₹560.55 · fair‑value band ₹42.24 – ₹70.40 · the ₹539.50 price screens above the ₹56.32 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

AMAGI (AMAGI) currently trades at ₹539.50, while our model-based Fair Value estimate is ₹56.32 — implying the stock looks roughly 89.6% overvalued today. We read business quality at 61/100 (solid quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, AMAGI generated revenue of ₹15.1B at a net margin of 4.8%. Revenue grew 28.5% year over year. It earns a return on equity of 6.3%. The stock trades on a trailing P/E of 163.2. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) ₹15.1B
Revenue growth (YoY) +28.5%
Net margin 4.8%
Return on equity 6.3%
Free cash flow −₹325M FY2026
P/E ratio 163.2
More key figures
Operating margin 4.5%
EPS (TTM) ₹3.31
EPS growth (YoY) +278%

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2023 – FY2026 · reported fiscal years

AMAGI reported revenue of ₹15.1B in FY2026 versus ₹6.8B in FY2023, a compound +30.3%/yr. Reported net income was ₹717M in FY2026.

Revenue +30.3%/yr
FY23 ₹6.8B
FY24 ₹8.8B
FY25 ₹11.6B
FY26 ₹15.1B
Net income
FY23 −₹3.2B
FY24 −₹2.5B
FY25 −₹687M
FY26 ₹717M

Is AMAGI fairly valued? → Check now

Similar stocks

6 more Software - Application stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock Price Fair Value vs Fair Value
SAP SE SAPP34 R$902.10 R$674.56 -25%
Salesforce, Inc CRM $170.92 $178.06 +4%
Uber Technologies, Inc UBER $68.61 $88.21 +29%
Shopify Inc SHOP $109.54 $30.42 -72%
ServiceNow, Inc NOW $127.65 $35.40 -72%
Cadence Design Systems, Inc CDNS $389.04 $80.41 -79%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is AMAGI (AMAGI) undervalued?
As of Jul 3, 2026, our model estimates a fair value of ₹56.32 versus a price of ₹539.50 — about −90% (overvalued). Model-based estimate, not financial advice.
What is the fair value of AMAGI?
Our model-based fair value for AMAGI is ₹56.32 (as of Jul 3, 2026), built from audited fundamentals. The current price is ₹539.50.
What is the quality score of AMAGI?
AMAGI has a Quality Score of 61/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of AMAGI (AMAGI)?
AMAGI reported trailing-twelve-month revenue of about ₹15.1B (latest available figure, as of Jul 3, 2026).
What is the net profit margin of AMAGI?
The net profit margin of AMAGI is about 4.8%, meaning it keeps roughly 4.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.